Tvardi Therapeutics (TVRD) Free Cash Flow: 2012-2024
Historic Free Cash Flow for Tvardi Therapeutics (TVRD) over the last 13 years, with Dec 2024 value amounting to -$62.0 million.
- Tvardi Therapeutics' Free Cash Flow rose 13.91% to -$11.4 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$54.9 million, marking a year-over-year decrease of 14.11%. This contributed to the annual value of -$62.0 million for FY2024, which is 34.40% up from last year.
- Tvardi Therapeutics' Free Cash Flow amounted to -$62.0 million in FY2024, which was up 34.40% from -$94.5 million recorded in FY2023.
- Tvardi Therapeutics' Free Cash Flow's 5-year high stood at -$5.8 million during FY2020, with a 5-year trough of -$94.5 million in FY2023.
- Its 3-year average for Free Cash Flow is -$78.4 million, with a median of -$78.8 million in 2022.
- Per our database at Business Quant, Tvardi Therapeutics' Free Cash Flow skyrocketed by 94.66% in 2020 and then slumped by 930.26% in 2021.
- Yearly analysis of 5 years shows Tvardi Therapeutics' Free Cash Flow stood at -$5.8 million in 2020, then crashed by 930.26% to -$60.1 million in 2021, then crashed by 31.01% to -$78.8 million in 2022, then fell by 19.91% to -$94.5 million in 2023, then surged by 34.40% to -$62.0 million in 2024.